Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New trials in resistant hypertension: mixed blessing stories
Carmine Zoccali, Francesca Mallamaci, Luca De Nicola, et al.
Clinical Kidney Journal (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 10

Showing 10 citing articles:

Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection
Alessio Mazzieri, Francesca Porcellati, Francesca Timio, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3969-3969
Open Access | Times Cited: 13
A novel scenario in the therapeutic management of anemia of chronic kidney disease: placement and use of roxadustat
Francesco Locatelli, Maura Ravera, Ciro Esposito, et al.
Journal of Nephrology (2024) Vol. 37, Iss. 4, pp. 1107-1119
Closed Access | Times Cited: 7
Resistance to erythropoiesis stimulating agents in a dialysis patient after kidney graft failure
Silvio Borrelli, Carlo Garofalo, Federica Marzano, et al.
Journal of Nephrology (2024)
Closed Access | Times Cited: 1
Risk Factors for Thromboembolic Events in Patients With Dialysis-Dependent CKD: Pooled Analysis of Four Global Roxadustat Phase 3 Trials
Takayuki Hamano, Yusuke Yamaguchi, Kashia Goto, et al.
Advances in Therapy (2024) Vol. 41, Iss. 4, pp. 1553-1575
Open Access | Times Cited: 1
Altered gut microbiota and metabolite profiles provide clues in understanding resistant hypertension
Jiuqi Guo, Pengyu Jia, Zhilin Gu, et al.
Journal of Hypertension (2024) Vol. 42, Iss. 7, pp. 1212-1225
Closed Access | Times Cited: 1
The Dual Endothelin-1 Antagonist Aprocitentan Alleviates Mitochondrial Oxidative Stress in Human Cardiac Fibroblasts
Fahimeh Varzideh, Stanislovas S. Jankauskas, Urja Jain, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2024) Vol. 10, Iss. 6, pp. 566-568
Closed Access
Catheter-based renal denervation in the treatment of arterial hypertension: An expert consensus statement on behalf of the SFHTA (French Society of Hypertension), SFR (French Society of Radiology), GACI (French Society of Interventional Cardiology), SFC (French Society of Cardiology), CNCF (French Association of Private Cardiologists), CNCH (French Association of Hospital Cardiologists), SFCTCV (French Society of Thoracic and Cardiovascular Surgery) and SCVE (French Society of Vascular and …
Atul Pathak, Romain Boulestreau, Marc Sapoval, et al.
Archives of cardiovascular diseases (2024) Vol. 117, Iss. 10, pp. 601-611
Open Access
Sub-Chronic Peroneal Nerve Stimulation Lowers Ambulatory Blood Pressure in Spontaneously Hypertensive Rats
Klaus Romero, María Alejandra González‐González, David Lloyd, et al.
IEEE Open Journal of Engineering in Medicine and Biology (2024) Vol. 6, pp. 140-146
Open Access
Aprocitentan: a new emerging prospect in the pharmacotherapy of hypertension
Lina Naseralallah, Somaya Koraysh
Blood Pressure (2024) Vol. 33, Iss. 1
Open Access
Approach to Resistant Hypertension: A Review of Recent Pharmacological Advances
Lorenzo V. Arvanitis, Christian Mewaldt, Anna K. Krawisz, et al.
Current Treatment Options in Cardiovascular Medicine (2024) Vol. 27, Iss. 1
Closed Access
Page 1

Scroll to top